Tissue Regenix Share Discussion Threads

[tnt99] 28/4/2022 07:18

A massive market that is cruciate ligament repair if this becomes the go to treatment it will be huge in its own right the war aspect could also be advents Gould to TRX

[clocktower] 27/4/2022 10:02

The sort of medical supplies TRX supplies must be in huge demand from the medics that have to treat the poor souls that are suffering from Russian aggression. I wonder if the international medical aid given to Ukraine would include many of the wound healing products produced by TRX?

[clocktower] 26/4/2022 16:58

The US market dragging almost everything down today it seems, with this slipping on relatively small volume but with the notice of the results of the votes at the AGM out of the way, I expect that as soon as the market bucks up, we will see a rapid turnaround with some micro cap major investors giving this a good look over, and maybe adding it to their portfolios, as it looks well placed to move up quickly on any news of a good contract or two.

[clocktower] 25/4/2022 12:23

Your nibble being bigger than mine today and a fraction cheaper mark. Well done.

Don't forget The AGM will be held at DLA Piper, 160 Aldersgate St, Barbican, London EC1A 4HT, on Tuesday 26 April 2022 at 1.00pm.

I guess the felling expressed will be very positive tomorrow.

[clocktower] 25/4/2022 12:01

I thought I would have another little nibble, as its weak today 250k - 0.51 shows as a sell on ADVFN.

Director buying the other day at over 0.54 with a good outlook. If it drops further, I go for another bite of the cherry.

[tnt99] 22/4/2022 08:05

Another director buy good to see and could move the share back to 1p by Christmas still very cheap at the mo

[clocktower] 21/4/2022 14:22

I hope it gets there well before 5 years CarrotandStick.

I am well in the Blue with this one, and will keep adding on weakness now.

It would not surprise me to find out that another director is buying, as a few of the MM's have taken on a lot of stock before dropping the bid while still keeping the offer, to shake out a few more. So a little dip before the next big step and maybe news in May to help it on its way.

[carrotandstick] 21/4/2022 07:06

I'm going to hold you to that Clocktower!

[clocktower] 20/4/2022 21:20

10 plus imo. The groundwork is done, the growth will flow.

[marktime1231] 20/4/2022 17:56

A few million shares for just a few thou, doesn't it make you want to buy some. I like the consensus that TRX has negotiated the bottom, prospects are all upwards from here, I would love to understand how big a market they could grow in to and at what margin.

What I mean to ask, is the 3-5 year horizon x 2 or x 10?

[clocktower] 20/4/2022 16:28

Another decent director buy.

[clocktower] 19/4/2022 13:27

It's good to see the two way trade and a few larger blocks being sold, as profits are taken and a new platform of .53 - .55 is being built as a solid base before taking the next step up towards a first target of .70

There is plenty of PI support and as you say quazie12, if a couple of microcaps start building a stake this could move well past my first target quickly.

Is there a chart expert following the thread that could comment on the recent and likely upward movement?

[clocktower] 19/4/2022 13:00

Thanks for the link GSG - Great report and well worth reading in full.

[quazie12] 19/4/2022 11:31

Just need a couple more microcap funds to start stake building as this moves towards ebitda breakevwn and profitability

[quazie12] 19/4/2022 11:30

They value coy on 4 * 2023 forecast revenues 90m sterling or roughly 1.25p

[gsg] 19/4/2022 07:43

Hardman & Co Research on Tissue Regenix (TRX): On pathway to sustainability

Tissue Regenix (TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL) and bone (BioRinse). It has a broad portfolio of commercial regenerative medicine products for the biosurgery, orthopaedics and dental markets. 2021 results contained the early benefits of TRX's strategic activities over the past two years - the focus on commercial relationships, capacity expansion, restructuring to service demand and recovery in elective surgeries. On the basis of continued sales progression, TRX is forecast to become EBITDA-positive in fiscal 2022 and cash-generative in 2023.

Please click on the link below for the full report:

[bloomberg2] 14/4/2022 13:30

https://audioboom.com/posts/8066986-vadim-alexandre-talks-about-tissue-regenix-polarean-s-new-ned

[ny boy] 14/4/2022 10:49

About time these recovered after being harshly sold off

Steady progress hopefully a sustained move to 1p + this year, will check back on progress in the autumn

[cyberbub] 14/4/2022 09:53

Marktime, Simply Wall Street articles are written by robots/AI, you can't rely on them for any proper analysis.

[gsg] 14/4/2022 09:37

Really interesting share price movement. mm's tried a half hearted shake first thing by opening up the spread to 8%, but soon gave up. Stock appears to be in tight supply. It wouldn't normally move on this low volume, so there must be a ii buyer in the background imo. A delayed print should show up eventually imo.

L2 now 2 v 2

[clocktower] 14/4/2022 08:37

Its good to see a little more two way trading start today, as these stocks rarely go up in a straight line without news.

I feel confident that after Easter we will see a further strong positive move and maybe a good RNS that might super charge it past 0.70 once again.

Have a Happy Easter one and all.

[quazie12] 14/4/2022 07:55

Sadly its not been management buying these in any meaningful quantity. I own more than those guys

[marktime1231] 13/4/2022 22:34

TRX stepping up, anticipating some good news or I wonder is this just because someone like Simply Wall Street has put out a note saying TRX are expected to breakeven during 2022?

[tnt99] 13/4/2022 16:12

I won't be selling any till we fly past 2p hopefully by this time next year